WASHINGTON — Judge Sonia Sotomayor carries a small black travel pouch, not much larger than a wallet. It contains the implements she needs — a blood sugar testing kit, a needle and insulin — to manage diabetes, a disease she has had for 46 years. Friends say she is not shy about using it.
Submitted by lipsie
THURSDAY, July 2 (HealthDay News) -- Children with type 1 diabetes are more likely to be overweight than those without the disease, increasing their risk of serious health complications, researchers say.
The finding is from a major study that explored the weight problems faced by U.S. youngsters with type 1 diabetes, a less common form of the disease that usually shows up in childhood or in young adults. The study, part of the "Search for... read more
Submitted by Judi62
Last week, a team of eight cyclists completed the coast-to-coast bike marathon called the Race Across America in record time. It was quite an achievement under any circumstances, but what made it extraordinary was something all eight of them had in common: Type 1 diabetes.
Submitted by Amy Tenderich
For more than a decade, MannKind Corp. of Valencia, Calif., has sunk about $1 billion into developing a fast-acting inhaled insulin, touting it as easier to take than frequent injections and medically superior to traditional medicines for controlling blood sugar.
Submitted by Amy Tenderich
Do any of the following sound familiar?
You’re trying to lose weight.
Your doctor told you your cholesterol is high and it needs to come down.
You found out you have diabetes, high blood pressure or cancer and you really need nutrition and diet information but don’t know where to turn.
You’ve had a heart attack and don’t want another one.
You’re tired of reading conflicting news stories about nutrition... read more
Submitted by Avera
The FDA is now reviewing a new inhalable insulin product called Afresa from MannKind Corp.
They're seeking approval for use in Type 1 or Type 2 diabetics to control high blood sugar levels -- claiming that their proprietary Technosphere technology enables this fast-acting insulin to be absorbed more easily and safely.
Submitted by Amy Tenderich
By transplanting embryonic pancreatic tissue from pigs to monkeys, Israeli researchers report that they were able to reverse the primates' insulin deficiency. Important steps for the progress of transplantation techniques?
Submitted by Amy Tenderich
After American and Brazilian researchers implanted 23 newly diagnosed type 1 patients with their own adult stem cells, 12 of the patients became insulin-free for periods lasting from 14 to 52 months (the mean was 31 months).
Submitted by Avera
What if you could make new virtual friends outside of your online acquaintances in social networks? And what if you could learn more about ways to better manage your diabetes at the same time?
This article explains the hot new online platform called Twitter.
Submitted by Amy Tenderich
TUESDAY, April 14 (HealthDay News) -- A particular type of stem cell transplantation using the patient's own cells led to short-term freedom from insulin injections in 20 of 23 patients newly diagnosed with type 1 diabetes participating in an experimental protocol in Brazil.
One patient even managed to go four years without needing outside sources of insulin, although the average was 31 months, said the authors of a report in the April 15 issue of... read more
Submitted by John Crowley